News

Emerging Robotic Exoskeleton Technologies is part of Frost & Sullivan's TechVision (Advanced Manufacturing Automation ... investing heavily in the research and development (R&D) of this technology.
This automation will be key to developing better therapies more efficiently, drug companies say, as research and development becomes more labor intensive amid the push toward more-tailored medicines.
By 2018, the national government alone had spent well in excess of $300 million funding research and development ... belief: Robots Will Save Japan. Japan is a pioneer in care automation.